Geneva Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Geneva Advisors's MDT Position: Q2 2017 in Review
Geneva Advisors increased its Medtronic (MDT) stake by 0.96% in Q2 2017, buying an estimated $16.9K and bringing the position to 21,059 shares worth $1.87M. The position accounts for 0.03% of the portfolio, ranked #235.
Geneva Advisors first reported a position in MDT in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.95M in Q2 2016. 1,281 funds tracked by Wall St. Rank hold MDT as of Q2 2017.
- Geneva Advisors held 21,059 shares of Medtronic worth $1.87M as of Q2 2017.
- Geneva Advisors bought 201 Medtronic shares in Q2 2017, an estimated $16.9K.
- Medtronic made up 0.03% of Geneva Advisors's portfolio in Q2 2017, its #235 holding.
- Geneva Advisors first reported a position in Medtronic in Q2 2013 and has held it in 17 quarters since.
- Geneva Advisors's Medtronic position peaked at $1.95M in Q2 2016.
- 1,281 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.